Olivia Putri Chairunnisa et al.trans. 2025. Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review. The Indonesian Journal of General Medicine. 12, 3 (May 2025), 1–48. DOI:https://doi.org/10.70070/vbsedq58.